GGrantIndex
Sort

130,381 grants matching hiv

Optimizing a Paraprofessional, Family Partner Navigation Model for Children

$839,524
Emily Feinberg · Boston Medical Center · R01 · FY2018 · MH

Structural determinants for integrase pleiotropism in viral maturation

$839,493
Mamuka Kvaratskhelia · Scripps Research Institute, The · U54 · FY2018 · GM

Glycan modification, CD4 independence, and Env immunogenicity

$839,486
Shiu-Lok Hu · University Of Washington · R01 · FY2010 · AI

Sex-differences in HIV persistence and Immune Dynamics during Reproductive Aging

$839,474
Sara Gianella Weibel · University Of California, San Diego · R01 · FY2023 · AI

Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia

$839,468
William A Zule · Research Triangle Institute · UH3 · FY2020 · DA

Lifespan/Tufts/brown Center for AIDS Research (CFAR)

$839,426
Susan Cu-Uvin · Miriam Hospital · P30 · FY2017 · AI

Novel Assays for measuring Integrase and RNase-H Inhibition

$839,400
Christos J Petropoulos · Monogram Biosciences, Inc. · R44 · FY2008 · AI

Family Planning Promotion in HIV Infected Zambians

$839,339
University Of Alabama At Birmingham · R01 · FY2001 · HD

Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.

$839,256
Sunnie Yoh · Scripps Research Institute, The · R01 · FY2024 · AI

Making women's options for HIV prevention in Tanzania accessible and joining implementation science capacity building (MWOTAJI)

$839,232
Mackfallen Giliadi Anasel · Centre Of Excellence In Health Monitoring And Evaluation · UG1 · FY2025 · HD

Nucleoside modified mRNA based HIV vaccine

$839,218
Drew Weissman · University Of Pennsylvania · R01 · FY2018 · AI

Molecular Therapeutics for HIVAIDS

$839,140
Dean H Hamer · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Effect of HIV and immunosuppression on oral HPV persistence in the HAART era

$839,140
Gypsyamber D'souza · Johns Hopkins University · R01 · FY2014 · DE

DEFINING THE INFANT IMMUNE RESPONSE TO HIV

$839,137
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2017 · AI

DEFINING THE INFANT IMMUNE RESPONSE TO HIV

$839,137
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI

DEFINING THE INFANT IMMUNE RESPONSE TO HIV

$839,137
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI

DEFINING THE INFANT IMMUNE RESPONSE TO HIV

$839,137
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2018 · AI

Health Systems Node of the NIDA Clinical Trials Network

$839,126
Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2023 · DA

Leveraging membrane Env liposome vaccine design to elicit multi-target cross-neutralization of HIV

$839,102
Michael B Zwick · Scripps Research Institute, The · R01 · FY2025 · AI

The Female Reproductive Tract as a Portal of HIV Infection

$839,093
Linda C Giudice · J. David Gladstone Institutes · P01 · FY2012 · AI

Virologic Correlates of Heterosexual Transmission

$839,042
Eric Hunter · Emory University · R37 · FY2008 · AI

Imaging Virological Synapses During Parenteral HIV Transmission

$839,025
Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · DP1 · FY2010 · DA

Combined prevention to reduce initiation into injecting drug use

$839,025
Don C Des Jarlais · Icahn School Of Medicine At Mount Sinai · DP1 · FY2016 · DA

Combined cocaine and HIV vaccine

$839,025
Timothy J Cardozo · New York University School Of Medicine · DP1 · FY2016 · DA

Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women

$838,967
Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2009 · HL